YS Biopharma Announces Appointment of New Directors : vimarsana.com

YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024. The six new directors are: Dr. Yuntao Cui; Dr. Jin Wang; Mr. Henry

Related Keywords

United States , Beijing , China , Shanxi , Fujian , Manhattan , New York , Jin Wang , Zhejiang , Zhong Lun , Jiangxi , California , Renmin , Liaoning , Philippines , Nigeria , Singapore , American , Ernst Young , Haitao Zhao , Chunyuan Brenda Wu , Yuntao Cui , Henry Chen , Pierson Yue Pan , Robin Yang , Rajit Shetty , Ys Group Biopharma , Counsel At Juventas Cell Therapy Ltd , China Civil Engineering Construction Company Nigeria , Source Ys Biopharma Co Ltd , American Pharmaceutical Professionals Association , Securities Exchange , Monument Pacific Development Corp , Nuokang Venture Fund , Berkeley Hass School Of Business , Rsys Group , Legal Affairs At Wanda Group , Senior Lawyer At Zhong Lun Law Firm , Worcester Polytechnic Institute , Company Interim Chairperson Of The Board , Manhattan Capital Investment Consulting Group , University Of Chemical Technology , Business Administration , Washington State University , Capital Investment , Renmin University Of China , Exchange Commission , University Of California , Shanxi University , International Law , Interim Chairperson , Senior Lawyer , Zhong Lun Law Firm , General Manager , Legal Affairs , Wanda Group , Senior Vice President , General Counsel , Juventas Cell Therapy Ltd , Renmin University , Founding Partner , Greater China Regional Director , Paramount Capital Investment , Biomedical Science , Worcester Polytechnic , Berkeley Hass School , Beijing University , Chemical Technology , Shanxi Tie Niu , Vice President , Monument Pacific Development , Project Development , Africa Market , Financial Controller , Senior Auditor , Washington State , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Biopharma , S Group , Iopharmaceutical Company , Lin Wang , Ierson Yue Pan , Mr Wang , Untao Cui , Hairperson Of The Board ,